GB0617117D0 - Method of diagnosis - Google Patents

Method of diagnosis

Info

Publication number
GB0617117D0
GB0617117D0 GBGB0617117.7A GB0617117A GB0617117D0 GB 0617117 D0 GB0617117 D0 GB 0617117D0 GB 0617117 A GB0617117 A GB 0617117A GB 0617117 D0 GB0617117 D0 GB 0617117D0
Authority
GB
United Kingdom
Prior art keywords
keloid
expression
scar
interest
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0617117.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Priority to GBGB0617117.7A priority Critical patent/GB0617117D0/en
Publication of GB0617117D0 publication Critical patent/GB0617117D0/en
Priority to PCT/GB2007/003232 priority patent/WO2008025963A2/en
Priority to AU2007291076A priority patent/AU2007291076A1/en
Priority to US12/439,301 priority patent/US20090280995A1/en
Priority to EP07789319A priority patent/EP2059612A2/en
Priority to CA002661705A priority patent/CA2661705A1/en
Priority to JP2009526165A priority patent/JP2010502940A/ja
Priority to ZA200900639A priority patent/ZA200900639B/xx
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0617117.7A 2006-08-31 2006-08-31 Method of diagnosis Ceased GB0617117D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0617117.7A GB0617117D0 (en) 2006-08-31 2006-08-31 Method of diagnosis
PCT/GB2007/003232 WO2008025963A2 (en) 2006-08-31 2007-08-28 Method of diagnosis
AU2007291076A AU2007291076A1 (en) 2006-08-31 2007-08-28 Method of diagnosis
US12/439,301 US20090280995A1 (en) 2006-08-31 2007-08-28 Method of diagnosis
EP07789319A EP2059612A2 (en) 2006-08-31 2007-08-28 Method of diagnosis
CA002661705A CA2661705A1 (en) 2006-08-31 2007-08-28 Method of diagnosis
JP2009526165A JP2010502940A (ja) 2006-08-31 2007-08-28 診断方法
ZA200900639A ZA200900639B (en) 2006-08-31 2007-08-28 Method of diagnosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0617117.7A GB0617117D0 (en) 2006-08-31 2006-08-31 Method of diagnosis

Publications (1)

Publication Number Publication Date
GB0617117D0 true GB0617117D0 (en) 2006-10-11

Family

ID=37137074

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0617117.7A Ceased GB0617117D0 (en) 2006-08-31 2006-08-31 Method of diagnosis

Country Status (8)

Country Link
US (1) US20090280995A1 (https=)
EP (1) EP2059612A2 (https=)
JP (1) JP2010502940A (https=)
AU (1) AU2007291076A1 (https=)
CA (1) CA2661705A1 (https=)
GB (1) GB0617117D0 (https=)
WO (1) WO2008025963A2 (https=)
ZA (1) ZA200900639B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015120350A2 (en) * 2014-02-07 2015-08-13 Effector Therapeutics, Inc. Compositions and methods for treating fibrotic disease
WO2016011143A1 (en) * 2014-07-15 2016-01-21 Temple University Of The Commonwealth System Of Higher Education Stabilized peptide fragments from redoxin proteins as cancer biomarkers
KR101667900B1 (ko) * 2016-01-15 2016-10-21 테고사이언스 (주) 켈로이드성 피부 또는 켈로이드 흉터 진단용 바이오마커 단백질 및 이의 이용
CN115616215B (zh) * 2021-07-13 2026-03-06 上海交通大学医学院附属第九人民医院 一种瘢痕诊断试剂及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040029114A1 (en) * 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
JP4344165B2 (ja) * 2003-04-21 2009-10-14 第一三共株式会社 ケロイドの診断方法

Also Published As

Publication number Publication date
CA2661705A1 (en) 2008-03-06
JP2010502940A (ja) 2010-01-28
EP2059612A2 (en) 2009-05-20
AU2007291076A1 (en) 2008-03-06
WO2008025963A3 (en) 2008-05-02
ZA200900639B (en) 2010-05-26
WO2008025963A2 (en) 2008-03-06
US20090280995A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
Butcher et al. Probe Lasso: a novel method to rope in differentially methylated regions with 450K DNA methylation data
MX2007009809A (es) Amplificacion de sonda por seleccion.
WO2008069906A3 (en) Digital expression of gene analysis
WO2020112604A3 (en) Analysis of multiple analytes using a single assay
WO2009113779A3 (ko) Ｓｎｐ 어레이를 이용한 염색체, 유전자, 또는 특정 뉴클레오티드 서열의 카피 수 측정방법
WO2009075799A3 (en) Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
EP2021534A4 (en) ESTIMATE AND REDUCE THE RISK OF GRAFT VERSUS HOST REACTION
WO2013033629A3 (en) Methods and compositions for the treatment and diagnosis of colorectal cancer
EP2021794B8 (en) Use of protein s100a 12 as a marker for colorectal cancer
WO2006138275A3 (en) Compositions and methods for treating and diagnosing cancer
EP4632078A3 (en) Methods and systems for monitoring organ health and disease
WO2009134944A3 (en) Methods of determining the health status of an individual
WO2010051314A3 (en) Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations
WO2009086215A3 (en) Pathway analysis of cell culture phenotypes and uses thereof
WO2008030845A3 (en) Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
WO2008025961A3 (en) Method of diagnosis
IS8314A (is) Ákvörðun fjölkirnisraðar
WO2011133949A3 (en) Genetic risk analysis in reward deficiency syndrome
WO2008054514A8 (en) Differential expression profiling analysis of cell culture phenotypes and the uses thereof
WO2009151757A3 (en) Method and apparatus for forensic screening
WO2008025963A3 (en) Method of diagnosis
WO2008157299A3 (en) Differential expression profiling analysis of cell culture phenotypes and uses thereof
EP2383349A3 (en) Primer and probe for detection of mycobacterium avium and method for detection of mycobacterium avium using the same
WO2005070086A3 (en) Methods and compositions for determining a graft tolerant phenotype in a subject

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)